Repligen's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Repligen's ROI in the second quarter of 2026?
Repligen Corp achieved a return on average invested assets (ROI) of 1.48 % in its second quarter of 2026, which is below Repligen's average return on investment, which stands at 4.87%.

ROI decreased relative to the period ending Mar 31 2026, due to the decline in net income.

Within the Healthcare sector 10 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1274 to 2151.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	2.98 %	3.45 %	2.75 %	0.93 %	5.92 %
Y / Y Net Income Change TTM	-	-	-	-65.65 %	-
Investment (TTM) in Millions	2,818	2,805	2,814	2,793	2,779
Return On Investment (TTM)	1.48 %	1.84 %	1.76 %	0.06 %	-0.51 %
RGEN's Overall Ranking	# 2151	# 1274	# 1499	# 2169	# 2061
Seq. Investment Change TTM	0.35 %	0.94 %	1.01 %	0.64 %	0.81 %
Seq. Net Income Change TTM	-19.18 %	5.12 %	2713.23 %	-	-
Net Income (TTM) in Millions	42	51	49	2	-14

RGEN Company Profile >> Back to RGEN Roi Comparisons >> See Annual RGEN Return On Investment

Return On Investment RGEN's Ranking
Within:	No.
Industry	# 0
Sector	# 11
Overall	# 2151

Return On Investment Statistics
High	Average	Low
22.54 %	4.87 %	-0.9 %
(Dec 31 2013)

News about Repligen Corp Return on Investment ROI

Repligen Unveils Training and Innovation Center to Enhance Biopharma Collaboration

September 24, 2024

In an exciting development for the biopharmaceutical industry, Repligen Corporation has inaugurated its Training and Innovation Center (RTIC), marking a significant commitment to elevating customer experience and fostering collaboration within the bioprocessing sector. Situated at the heart of Repligen s operations, the new center is poised to support biopharma and Contract Development and Manufacturing Organizations (CDMOs) in harnessing the full potential of advanced bioprocessing technologies.The biopharmaceutical landscape has undergone rapid transformation in recent years, driven by the demand for more efficient, cost-effective production methods and the onus of meeting stringent regulatory standards. As companies strive to expedite the development of biologics and biosimilars, they require robust support systems that can keep pace with their evolving needs. Repligen’s RTIC is designed to address these challenges head-on, enhancing the customer journey through hands-on training and innovative solutions tailored to individual project requirements.

Financial Statements
Repligen's II. Quarter Investments	$ 2,818 Millions	RGEN's Balance sheet
Repligen's II. Quarter Income	$ 5 Millions	Quarterly RGEN's Income Statement
RGEN's Income by Division		See RGEN's Income by Division

RGEN Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	2,814	2,703	2,666	2,120	1,983
Y / Y Investment Growth	4.11 %	1.37 %	25.74 %	6.93 %	27.32 %
Net Income in Millions	49	-26	36	186	128
Y / Y Net Income Growth	-	-	-80.86 %	44.95 %	114.08 %
Annual Return On Investment	1.74 %	-0.94 %	1.34 %	8.77 %	6.47 %

Annual Roi Comment

In the fiscal year 2025 ROI improved to 1.74 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RGEN's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RGEN's Competitors
Subscribers only: Roi for Repligen's Suppliers
Subscribers only: Return On Investment for RGEN's Customers

Other Ratios
RGEN's Roa	RGEN's Inventory Turnover Ratio	RGEN's Growth Rates	RGEN's Dividend Statistics
	RGEN's Profitability Ratios	RGEN's Asset Turnover Ratio	RGEN's Dividend Growth
RGEN's Roe	RGEN's Valuation Ratios	RGEN's Financial Strength Ratios	RGEN's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector	ROI
Zimmer Biomet Holdings Inc	3.97 %
U S Physical Therapy Inc	3.91 %
Privia Health Group Inc	3.90 %
Integer Holdings Corporation	3.88 %
Ardent Health Inc	3.74 %
Collegium Pharmaceutical Inc	3.72 %
Merck and Co Inc	3.24 %
Community Health Systems Inc	3.12 %
National Vision Holdings Inc	2.99 %
Teva Pharmaceutical Industries Limited	2.66 %
Lifestance Health Group Inc	2.61 %
Conmed Corporation	2.57 %
Pfizer Inc	2.53 %
Mimedx Group Inc	2.38 %
Bio rad Laboratories Inc	2.34 %
Lifemd Inc	2.32 %
Alkermes Plc	2.31 %
Becton Dickinson And Company	2.22 %
Revvity Inc	2.18 %
Envista Holdings Corporation	2.06 %
Immucell Corporation	1.95 %
Atricure Inc	1.84 %
Black Hawk Acquisition Corporation	1.79 %
Omada Health Inc	1.70 %
Arvinas Inc	1.53 %
Repligen Corp	1.41 %
Cormedix Inc	1.31 %
Pacira Biosciences inc	1.29 %
Waters Corporation	1.20 %
Surgery Partners Inc	1.02 %

Date modified: 2026-09-26T07:09:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.